Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Calcified Tissue International|September 23, 2000
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapyS Wallach, S Cohen, D M Reid, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 2011
A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 yearsIan R Reid, Kenneth Lyles, Guoqin Su, et al.
International Journal of Cancer|May 27, 2010
Allergy and glioma risk: test of association by genotypeSara E Dobbins, Fay J Hosking, Sanjay Shete, et al.
Blood|March 17, 2010
Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia riskFay J Hosking, Elli Papaemmanuil, Eammon Sheridan, et al.
Menopause (New York, N.Y.)|November 17, 2004
Changes in bone density and turnover after alendronate or estrogen withdrawalRichard D Wasnich, Yu Z Bagger, David J Hosking, et al.
QJM : Monthly Journal of the Association of Physicians|May 14, 1998
Management of male osteoporosis: report of the UK Consensus GroupR Eastell, I T Boyle, J Compston, et al.
Journal of Internal Medicine|November 3, 1998
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an updateR Eastell, D M Reid, J Compston, et al.
QJM : Monthly Journal of the Association of Physicians|November 13, 2001
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?R Eastell, D M Reid, J Compston, et al.
Pageof 20